Comparative Absorption of a Standardized Curcuminoid Mixture and Its Lecithin Formulation
Top Cited Papers
- 17 March 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 74 (4), 664-669
- https://doi.org/10.1021/np1007262
Abstract
The relative absorption of a standardized curcuminoid mixture and its corresponding lecithin formulation (Meriva) was investigated in a randomized, double-blind, crossover human study. Clinically validated dosages were used for both products, and plasma levels of all three major curcuminoids [curcumin (1a), demethoxycurcumin (1b), and bisdemethoxycurcumin (1c)] were evaluated. Total curcuminoid absorption was about 29-fold higher for Meriva than for its corresponding unformulated curcuminoid mixture, but only phase-2 metabolites could be detected, and plasma concentrations were still significantly lower than those required for the inhibition of most anti-inflammatory targets of curcumin. Remarkably, phospholipid formulation increased the absorption of demethoxylated curcuminoids much more than that of curcumin (1a), with significant differences in plasma curcuminoid profile between Meriva and its corresponding unformulated curcuminoid mixture. Thus, the major plasma curcuminoid after administration of Meriva was not curcumin (1a), but demethoxycurcumin (1b), a more potent analogue in many in vitro anti-inflammatory assays. The improved absorption, and possibly also a better plasma curcuminoid profile, might underlie the clinical efficacy of Meriva at doses significantly lower than unformulated curcuminoid mixtures.Keywords
This publication has 36 references indexed in Scilit:
- Curcumin as a therapeutic agent: the evidence fromin vitro, animal and human studiesBritish Journal of Nutrition, 2010
- Systemic delivery of curcumin: 21st century solutions for an ancient conundrum.Current Drug Discovery Technologies, 2009
- Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targetsTrends in Pharmacological Sciences, 2008
- Biological activities of curcumin and its analogues (Congeners) made by man and Mother NatureBiochemical Pharmacology, 2008
- Multi‐targeted therapy by curcumin: how spicy is it?Molecular Nutrition & Food Research, 2008
- Bioavailability of Curcumin: Problems and PromisesMolecular Pharmaceutics, 2007
- Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)BMC Clinical Pharmacology, 2005
- Target-based drug discovery: is something wrong?Drug Discovery Today, 2005
- Multicomponent therapeutics for networked systemsNature Reviews Drug Discovery, 2005
- From magic bullets to designed multiple ligandsDrug Discovery Today, 2004